CIK 0001659617
- Non-accelerated filer
- Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474671997
- Phone
- +1 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | Foster Jonathan P. Chief Financial Officer | Option exercise | +41 | 20,301 | ||
| 2026-11-04 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −10 | $8.46 | $85 | 20,291 |
| 2026-11-04 | Foster Jonathan P. Chief Financial Officer | Option exercise · Restricted Stock Units | −41 | 70,854 | ||
| 2026-10-15 | Foster Jonathan P. Chief Financial Officer | Option exercise | +130,000 | 435,673 | ||
| 2026-10-15 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −30,485 | $0.37 | $11K | 405,188 |
| 2026-10-15 | Foster Jonathan P. Chief Financial Officer | Grant or award · Stock Options (right to buy) | +260,000 | 1,287,717 | ||
| 2026-10-15 | Foster Jonathan P. Chief Financial Officer | Grant or award · Restricted Stock Units | +260,000 | 1,547,717 | ||
| 2026-10-15 | Foster Jonathan P. Chief Financial Officer | Option exercise · Restricted Stock Units | −130,000 | 1,417,717 | ||
| 2026-08-03 | Foster Jonathan P. Chief Financial Officer | Purchase | +293,333 | 305,673 | ||
| 2026-08-03 | Foster Jonathan P. Chief Financial Officer | Purchase · Series I Warrants | +879,999 | 1,027,717 | ||
| 2026-06-22 | Foster Jonathan P. Chief Financial Officer | Option exercise | +174 | 12,381 | ||
| 2026-06-22 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −41 | $3.12 | $128 | 12,340 |
| 2026-06-22 | Foster Jonathan P. Chief Financial Officer | Option exercise · Restricted Stock Units | −174 | 147,718 | ||
| 2026-06-20 | Foster Jonathan P. Chief Financial Officer | Option exercise | +109 | 12,238 | ||
| 2026-06-20 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −31 | $2.88 | $89 | 12,207 |
| 2026-06-20 | Foster Jonathan P. Chief Financial Officer | Option exercise · Restricted Stock Units | −109 | 147,892 | ||
| 2025-11-12 | Foster Jonathan P. EVP & CFO | Grant or award · Stock option (right to buy) | +600,000 | 1,617,695 | ||
| 2025-11-12 | Foster Jonathan P. EVP & CFO | Grant or award · Performance Based Restricted Stock Units | +400,000 | 2,017,695 | ||
| 2025-11-04 | Foster Jonathan P. Chief Financial Officer | Option exercise | +20,625 | 308,212 | ||
| 2025-11-04 | Foster Jonathan P. Chief Financial Officer | Option exercise | −5,023 | $0.50 | $2K | 303,189 |
Page 1 of 4 · 66 trades